PB 77 of 2013
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 4)
National Health Act 1953
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.
Dated 26 November 2013
FELICITY MCNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
1 Name of Determination
(1) This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 4).
(2) This Determination may also be cited as PB 77 of 2013.
2 Commencement
This Determination commences on 1 December 2013.
3 Amendments to PB 1 of 2010
Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).
Schedule 1 Amendments
[1] Schedule 1, Part 7
omit:
1
Atorvastatin
[2] Schedule 1, Part 8
omit:
2
Venlafaxine